Stage III Gallbladder Cancer AJCC V7
3 clinical trials · Condition
◉ Watch Stage III Gallbladder Cancer AJCC V7
| Record | Firm | Date |
|---|---|---|
| Guadecitabine and Durvalumab in Treating Patients With Advanced Liver, Pancreatic, Bile Duct, or Gallbladder Cancer (NCT03257761) | University of Southern California | 2018-02-07 |
| TAS-102 in Treating Advanced Biliary Tract Cancers (NCT03278106) | Mayo Clinic | 2017-10-20 |
| Ramucirumab in Treating Patients With Advanced or Metastatic, Previously Treated Biliary Cancers That Cannot Be Removed by Surgery (NCT02520141) | M.D. Anderson Cancer Center | 2015-12-29 |
Track Stage III Gallbladder Cancer AJCC V7 automatically
Every clearance here is in the API, with alerts when new ones post.